Product Information
TAMSULOSIN HCL 0.4 MG CAPSULE is a generic product labeled by Major Pharmaceuticals, priced at $0.0500 per EA under NDC 00904738361. Its NADAC has been published 137 times since Feb 21, 2024.
FDA first approved this application on Apr 30, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.4 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904738361
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TAMSULOSIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202433FDA Approved
4/30/2013
TE Code
AB
On Market Since
4/30/2013
Pharmacological Classes
Price Statistics
The NADAC for TAMSULOSIN HCL 0.4 MG CAPSULE has been published 137 times since Feb 21, 2024, and over the history we have for it it has declined 7.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0500 per EA |
|---|---|
| All-time high | $0.0580 (Apr 10, 2024) |
| All-time low | $0.0435 (Nov 20, 2024) |
| 52-week high | $0.0522 |
| 52-week low | $0.0494 |
| Median price | $0.0513 |
| Average price | $0.0512 |
| Largest weekly change | -19.3% (Apr 17, 2024) |
| Weeks tracked | 137 |
| Tracking since | Feb 21, 2024 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tamsulosin Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TAMSULOSIN HCL 0.4 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TAMSULOSIN HCL 0.4 MG CAPSULE, manufactured by Major Pharmaceuticals, is $0.0500 per EA (NDC 00904738361), effective Sep 30, 2026.
How has the price of TAMSULOSIN HCL 0.4 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TAMSULOSIN HCL 0.4 MG CAPSULE has declined 7.0%. It has been tracked across 137 weekly CMS publications since Feb 21, 2024.
What are the highest and lowest recorded NADAC prices for TAMSULOSIN HCL 0.4 MG CAPSULE?
Since Feb 21, 2024, the NADAC for TAMSULOSIN HCL 0.4 MG CAPSULE has ranged from a low of $0.0435 (Nov 20, 2024) to a high of $0.0580 (Apr 10, 2024), with a median of $0.0513 per EA.
Are there cheaper alternatives to TAMSULOSIN HCL 0.4 MG CAPSULE?
11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TAMSULOSIN HCL 0.4 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TAMSULOSIN HCL 0.4 MG CAPSULE?
TAMSULOSIN HCL 0.4 MG CAPSULE (NDC 00904738361) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.